{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T16:31:40Z","timestamp":1780849900127,"version":"3.54.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,1,13]],"date-time":"2024-01-13T00:00:00Z","timestamp":1705104000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,13]],"date-time":"2024-01-13T00:00:00Z","timestamp":1705104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["1.1.1.2\/VIAA\/4\/20\/728"],"award-info":[{"award-number":["1.1.1.2\/VIAA\/4\/20\/728"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biotechnol"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1007\/s12033-023-01021-5","type":"journal-article","created":{"date-parts":[[2024,1,13]],"date-time":"2024-01-13T13:01:50Z","timestamp":1705150910000},"page":"1206-1219","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Preclinical Evaluation of virus-like particle Vaccine Against Carbonic Anhydrase IX Efficacy in a Mouse Breast Cancer Model System"],"prefix":"10.1007","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9002-3131","authenticated-orcid":false,"given":"Zane","family":"Kalni\u0146a","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilva","family":"Liekni\u0146a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vendija","family":"Skeltona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In\u0101ra","family":"Akopjana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andris","family":"Kaz\u0101ks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaspars","family":"T\u0101rs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,13]]},"reference":[{"key":"1021_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021). Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 71, 209\u2013249.","journal-title":"CA: A Cancer Journal for Clinicians"},{"key":"1021_CR2","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1126\/science.342.6165.1432","volume":"342","author":"J Couzin-Frankel","year":"2013","unstructured":"Couzin-Frankel, J. (2013). Breakthrough of the year 2013.\u00a0Cancer immunotherapy. Science, 342, 1432\u20131433.","journal-title":"Science"},{"key":"1021_CR3","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1016\/j.annonc.2021.08.2153","volume":"32","author":"G Antonarelli","year":"2021","unstructured":"Antonarelli, G., Corti, C., Tarantino, P., Ascione, L., Cortes, J., Romero, P., Mittendorf, E. A., Disis, M. L., & Curigliano, G. (2021). Therapeutic cancer vaccines revamping: Technology advancements and pitfalls. Annals of Oncology, 32, 1537\u20131551.","journal-title":"Annals of Oncology"},{"key":"1021_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines8040615","author":"L Buonaguro","year":"2020","unstructured":"Buonaguro, L., & Tagliamonte, M. (2020). Selecting target antigens for cancer vaccine development. Vaccines (Basel). https:\/\/doi.org\/10.3390\/vaccines8040615","journal-title":"Vaccines (Basel)"},{"key":"1021_CR5","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1159\/000449503","volume":"59","author":"P Pumpens","year":"2016","unstructured":"Pumpens, P., Renhofa, R., Dishlers, A., Kozlovska, T., Ose, V., Pushko, P., Tars, K., Grens, E., & Bachmann, M. F. (2016). The True Story and Advantages of RNA Phage Capsids as Nanotools. Intervirology, 59, 74\u2013110.","journal-title":"Intervirology"},{"key":"1021_CR6","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1515\/BC.2008.064","volume":"389","author":"GT Jennings","year":"2008","unstructured":"Jennings, G. T., & Bachmann, M. F. (2008). The coming of age of virus-like particle vaccines. Biological Chemistry, 389, 521\u2013536.","journal-title":"Biological Chemistry"},{"key":"1021_CR7","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/978-981-10-8456-0_13","volume":"88","author":"J Rumnieks","year":"2018","unstructured":"Rumnieks, J., & Tars, K. (2018). Protein-RNA Interactions in the Single-Stranded RNA Bacteriophages. SubCellular Biochemistry, 88, 281\u2013303.","journal-title":"SubCellular Biochemistry"},{"key":"1021_CR8","doi-asserted-by":"publisher","first-page":"4621","DOI":"10.1093\/nar\/21.19.4621","volume":"21","author":"GG Pickett","year":"1993","unstructured":"Pickett, G. G., & Peabody, D. S. (1993). Encapsidation of heterologous RNAs by bacteriophage MS2 coat protein. Nucleic Acids Research, 21, 4621\u20134626.","journal-title":"Nucleic Acids Research"},{"key":"1021_CR9","doi-asserted-by":"publisher","first-page":"6019","DOI":"10.1016\/j.vaccine.2020.07.016","volume":"38","author":"I Lieknina","year":"2020","unstructured":"Lieknina, I., Cernova, D., Rumnieks, J., & Tars, K. (2020). Novel ssRNA phage VLP platform for displaying foreign epitopes by genetic fusion. Vaccine, 38, 6019\u20136026.","journal-title":"Vaccine"},{"issue":"279\u2013281","key":"1021_CR10","volume":"142","author":"MF Bachmann","year":"2018","unstructured":"Bachmann, M. F., Zeltins, A., Kalnins, G., Balke, I., Fischer, N., Rostaher, A., Tars, K., & Favrot, C. (2018). Vaccination against IL-31 for the treatment of atopic dermatitis in dogs. The Journal of Allergy and Clinical Immunology, 142(279\u2013281), e271.","journal-title":"The Journal of Allergy and Clinical Immunology"},{"key":"1021_CR11","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1111\/all.13659","volume":"74","author":"A Fettelschoss-Gabriel","year":"2019","unstructured":"Fettelschoss-Gabriel, A., Fettelschoss, V., Olomski, F., Birkmann, K., Thoms, F., Buhler, M., Kummer, M., Zeltins, A., Kundig, T. M., & Bachmann, M. F. (2019). Active vaccination against interleukin-5 as long-term treatment for insect-bite hypersensitivity in horses. Allergy, 74, 572\u2013582.","journal-title":"Allergy"},{"key":"1021_CR12","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/S0140-6736(08)60381-5","volume":"371","author":"AC Tissot","year":"2008","unstructured":"Tissot, A. C., Maurer, P., Nussberger, J., Sabat, R., Pfister, T., Ignatenko, S., Volk, H. D., Stocker, H., Muller, P., Jennings, G. T., Wagner, F., & Bachmann, M. F. (2008). Effect of immunisation against angiotensin II with CYT006-AngQb on ambulatory blood pressure: A double-blind, randomised, placebo-controlled phase IIa study. Lancet, 371, 821\u2013827.","journal-title":"Lancet"},{"key":"1021_CR13","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1038\/mt.2015.227","volume":"24","author":"C Cavelti-Weder","year":"2016","unstructured":"Cavelti-Weder, C., Timper, K., Seelig, E., Keller, C., Osranek, M., Lassing, U., Spohn, G., Maurer, P., Muller, P., Jennings, G. T., Willers, J., Saudan, P., Donath, M. Y., & Bachmann, M. F. (2016). Development of an interleukin-1beta vaccine in patients with type 2 diabetes. Molecular Therapy, 24, 1003\u20131012.","journal-title":"Molecular Therapy"},{"key":"1021_CR14","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s12943-015-0384-3","volume":"14","author":"DK Chang","year":"2015","unstructured":"Chang, D. K., Moniz, R. J., Xu, Z., Sun, J., Signoretti, S., Zhu, Q., & Marasco, W. A. (2015). Human anti-CAIX antibodies mediate immune cell inhibition of renal cell carcinoma in vitro and in a humanized mouse model in vivo. Molecular Cancer, 14, 119.","journal-title":"Molecular Cancer"},{"key":"1021_CR15","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1006\/geno.1996.0223","volume":"33","author":"R Opavsky","year":"1996","unstructured":"Opavsky, R., Pastorekova, S., Zelnik, V., Gibadulinova, A., Stanbridge, E. J., Zavada, J., Kettmann, R., & Pastorek, J. (1996). Human MN\/CA9 gene, a novel member of the carbonic anhydrase family: Structure and exon to protein domain relationships. Genomics, 33, 480\u2013487.","journal-title":"Genomics"},{"key":"1021_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0002-9440(10)65537-X","volume":"153","author":"A Nogradi","year":"1998","unstructured":"Nogradi, A. (1998). The role of carbonic anhydrases in tumors. American Journal of Pathology, 153, 1\u20134.","journal-title":"American Journal of Pathology"},{"key":"1021_CR17","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3389\/fonc.2016.00069","volume":"6","author":"SJ van Kuijk","year":"2016","unstructured":"van Kuijk, S. J., Yaromina, A., Houben, R., Niemans, R., Lambin, P., & Dubois, L. J. (2016). Prognostic significance of carbonic anhydrase IX expression in cancer patients: A meta-analysis. Frontiers in Oncology, 6, 69.","journal-title":"Frontiers in Oncology"},{"key":"1021_CR18","first-page":"2877","volume":"9","author":"J Pastorek","year":"1994","unstructured":"Pastorek, J., Pastorekova, S., Callebaut, I., Mornon, J. P., Zelnik, V., Opavsky, R., Zat\u2019ovicova, M., Liao, S., Portetelle, D., Stanbridge, E. J., et al. (1994). Cloning and characterization of MN, a human tumor-associated protein with a domain homologous to carbonic anhydrase and a putative helix-loop-helix DNA binding segment. Oncogene, 9, 2877\u20132888.","journal-title":"Oncogene"},{"key":"1021_CR19","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/j.semcancer.2022.01.001","volume":"86","author":"A Queen","year":"2022","unstructured":"Queen, A., Bhutto, H. N., Yousuf, M., Syed, M. A., & Hassan, M. I. (2022). Carbonic anhydrase IX: A tumor acidification switch in heterogeneity and chemokine regulation. Seminars in Cancer Biology, 86, 899\u2013913.","journal-title":"Seminars in Cancer Biology"},{"key":"1021_CR20","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s10555-019-09799-0","volume":"38","author":"S Pastorekova","year":"2019","unstructured":"Pastorekova, S., & Gillies, R. J. (2019). The role of carbonic anhydrase IX in cancer development: Links to hypoxia, acidosis, and beyond. Cancer and Metastasis Reviews, 38, 65\u201377.","journal-title":"Cancer and Metastasis Reviews"},{"key":"1021_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/molecules23051045","author":"S Singh","year":"2018","unstructured":"Singh, S., Lomelino, C. L., Mboge, M. Y., Frost, S. C., & McKenna, R. (2018). Cancer drug development of carbonic anhydrase inhibitors beyond the active site. Molecules. https:\/\/doi.org\/10.3390\/molecules23051045","journal-title":"Molecules"},{"key":"1021_CR22","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1080\/14756366.2022.2052868","volume":"37","author":"M Kciuk","year":"2022","unstructured":"Kciuk, M., Gielecinska, A., Mujwar, S., Mojzych, M., Marciniak, B., Drozda, R., & Kontek, R. (2022). Targeting carbonic anhydrase IX and XII isoforms with small molecule inhibitors and monoclonal antibodies. Journal of Enzyme Inhibition and Medicinal Chemistry, 37, 1278\u20131298.","journal-title":"Journal of Enzyme Inhibition and Medicinal Chemistry"},{"key":"1021_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14061392","author":"NSP Campos","year":"2022","unstructured":"Campos, N. S. P., Souza, B. S., Silva, G., Porto, V. A., Chalbatani, G. M., Lagreca, G., Janji, B., & Suarez, E. R. (2022). Carbonic anhydrase IX: A renewed target for cancer immunotherapy. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers14061392","journal-title":"Cancers (Basel)"},{"key":"1021_CR24","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1038\/sj.bjc.6601617","volume":"90","author":"I Bleumer","year":"2004","unstructured":"Bleumer, I., Knuth, A., Oosterwijk, E., Hofmann, R., Varga, Z., Lamers, C., Kruit, W., Melchior, S., Mala, C., Ullrich, S., De Mulder, P., Mulders, P. F., & Beck, J. (2004). A phase II trial of chimeric monoclonal antibody G250 for advanced renal cell carcinoma patients. British Journal of Cancer, 90, 985\u2013990.","journal-title":"British Journal of Cancer"},{"key":"1021_CR25","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1001\/jamaoncol.2016.4419","volume":"3","author":"K Chamie","year":"2017","unstructured":"Chamie, K., Donin, N. M., Klopfer, P., Bevan, P., Fall, B., Wilhelm, O., Storkel, S., Said, J., Gambla, M., Hawkins, R. E., Jankilevich, G., Kapoor, A., Kopyltsov, E., Staehler, M., Taari, K., Wainstein, A. J. A., Pantuck, A. J., & Belldegrun, A. S. (2017). Adjuvant weekly girentuximab following nephrectomy for high-risk renal cell carcinoma: The ARISER randomized clinical trial. JAMA Oncology, 3, 913\u2013920.","journal-title":"JAMA Oncology"},{"key":"1021_CR26","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.semcancer.2021.06.015","volume":"82","author":"Z Hua","year":"2022","unstructured":"Hua, Z., White, J., & Zhou, J. (2022). Cancer stem cells in TNBC. Seminars in Cancer Biology, 82, 26\u201334.","journal-title":"Seminars in Cancer Biology"},{"key":"1021_CR27","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s13058-022-01532-0","volume":"24","author":"CHC Ong","year":"2022","unstructured":"Ong, C. H. C., Lee, D. Y., Lee, B., Li, H., Lim, J. C. T., Lim, J. X., Yeong, J. P. S., Lau, H. Y., Thike, A. A., Tan, P. H., & Iqbal, J. (2022). Hypoxia-regulated carbonic anhydrase IX (CAIX) protein is an independent prognostic indicator in triple negative breast cancer. Breast Cancer Research, 24, 38.","journal-title":"Breast Cancer Research"},{"key":"1021_CR28","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s00280-014-2635-1","volume":"75","author":"L Ivanova","year":"2015","unstructured":"Ivanova, L., Zandberga, E., Silina, K., Kalnina, Z., Abols, A., Endzelins, E., Vendina, I., Romanchikova, N., Hegmane, A., Trapencieris, P., Eglitis, J., & Line, A. (2015). Prognostic relevance of carbonic anhydrase IX expression is distinct in various subtypes of breast cancer and its silencing suppresses self-renewal capacity of breast cancer cells. Cancer Chemotherapy and Pharmacology, 75, 235\u2013246.","journal-title":"Cancer Chemotherapy and Pharmacology"},{"key":"1021_CR29","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1053\/gast.1997.v112.pm9024293","volume":"112","author":"S Pastorekova","year":"1997","unstructured":"Pastorekova, S., Parkkila, S., Parkkila, A. K., Opavsky, R., Zelnik, V., Saarnio, J., & Pastorek, J. (1997). Carbonic anhydrase IX, MN\/CA IX: Analysis of stomach complementary DNA sequence and expression in human and rat alimentary tracts. Gastroenterology, 112, 398\u2013408.","journal-title":"Gastroenterology"},{"key":"1021_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21010246","author":"M Takacova","year":"2019","unstructured":"Takacova, M., Barathova, M., Zatovicova, M., Golias, T., Kajanova, I., Jelenska, L., Sedlakova, O., Svastova, E., Kopacek, J., & Pastorekova, S. (2019). Carbonic anhydrase IX-mouse versus human. International Journal of Molecular Sciences. https:\/\/doi.org\/10.3390\/ijms21010246","journal-title":"International Journal of Molecular Sciences"},{"key":"1021_CR31","doi-asserted-by":"publisher","first-page":"9004","DOI":"10.1021\/acs.jmedchem.5b01343","volume":"58","author":"J Leitans","year":"2015","unstructured":"Leitans, J., Kazaks, A., Balode, A., Ivanova, J., Zalubovskis, R., Supuran, C. T., & Tars, K. (2015). Efficient expression and crystallization system of cancer-associated carbonic anhydrase isoform IX. Journal of Medicinal Chemistry, 58, 9004\u20139009.","journal-title":"Journal of Medicinal Chemistry"},{"key":"1021_CR32","doi-asserted-by":"publisher","first-page":"3199","DOI":"10.1002\/cbic.202100381","volume":"22","author":"KD Brune","year":"2021","unstructured":"Brune, K. D., Lieknina, I., Sutov, G., Morris, A. R., Jovicevic, D., Kalnins, G., Kazaks, A., Kluga, R., Kastaljana, S., Zajakina, A., Jansons, J., Skrastina, D., Spunde, K., Cohen, A. A., Bjorkman, P. J., Morris, H. R., Suna, E., & Tars, K. (2021). N-terminal modification of Gly-his-tagged proteins with azidogluconolactone. ChemBioChem, 22, 3199\u20133207.","journal-title":"ChemBioChem"},{"key":"1021_CR33","unstructured":"Kalni\u0146a, Z.L., I., Kotelovi\u010da, S., Petrovska, R., Laugalis, M.T., Skeltona, V., Jansons, J., Kreishmane, M., T\u0101rs, K. (2023) Development of 4T1 breast cancer mouse model system for preclinical carbonic anhydrase IX studies. Submitted to Heliyon."},{"key":"1021_CR34","unstructured":"G*Power Statistical Power Analyses for Mac and Windows. Available from: http:\/\/www.gpower.hhu.de\/."},{"key":"1021_CR35","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3758\/BF03193146","volume":"39","author":"F Faul","year":"2007","unstructured":"Faul, F., Erdfelder, E., Lang, A. G., & Buchner, A. (2007). G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behavior Research Methods, 39, 175\u2013191.","journal-title":"Behavior Research Methods"},{"key":"1021_CR36","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1177\/0023677213516312","volume":"48","author":"M Mahler-Convenor","year":"2014","unstructured":"FELASA Working Group on Revision of Guidelines for Health Monitoring of Rodents and Rabbits, Mahler-Convenor, M., Berard, M., Feinstein, R., Gallagher, A., Illgen-Wilcke, B., Pritchett-Corning, K., & Raspa, M. (2014). FELASA recommendations for the health monitoring of mouse rat hamster guinea pig and rabbit colonies in breeding and experimental units. Laboratory Animals, 48, 178\u2013192.","journal-title":"Laboratory Animals"},{"key":"1021_CR37","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1038\/sj.bjc.6605642","volume":"102","author":"P Workman","year":"2010","unstructured":"Workman, P., Aboagye, E. O., Balkwill, F., Balmain, A., Bruder, G., Chaplin, D. J., Double, J. A., Everitt, J., Farningham, D. A., Glennie, M. J., Kelland, L. R., Robinson, V., Stratford, I. J., Tozer, G. M., Watson, S., Wedge, S. R., & Eccles, S. A. (2010). Guidelines for the welfare and use of animals in cancer research. British Journal of Cancer, 102, 1555\u20131577.","journal-title":"British Journal of Cancer"},{"key":"1021_CR38","unstructured":"Expert Working Group (Animal Welfare Body of the European Commission). (2013). Examples to illustrate the process of severity classification, day-to-day assessment and actual severity assessment. European Commission. [Cited 1 Mar 2021]. Available from: https:\/\/ec.europa.eu\/environment\/chemicals\/lab_animals\/pdf\/examples.pdf."},{"key":"1021_CR39","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/978-1-60761-849-2_4","volume":"691","author":"M Slaoui","year":"2011","unstructured":"Slaoui, M., & Fiette, L. (2011). Histopathology procedures: From tissue sampling to histopathological evaluation. Methods in Molecular Biology, 691, 69\u201382.","journal-title":"Methods in Molecular Biology"},{"key":"1021_CR40","doi-asserted-by":"publisher","DOI":"10.1201\/b22819","volume-title":"Virus-Like Particles: A Comprehensive Guide","author":"P Pumpens","year":"2022","unstructured":"Pumpens, P., & Pushko, P. (2022). Virus-Like Particles: A Comprehensive Guide. CRC Press."},{"key":"1021_CR41","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1126\/science.1118948","volume":"310","author":"F Nimmerjahn","year":"2005","unstructured":"Nimmerjahn, F., & Ravetch, J. V. (2005). Divergent immunoglobulin g subclass activity through selective Fc receptor binding. Science, 310, 1510\u20131512.","journal-title":"Science"},{"key":"1021_CR42","doi-asserted-by":"publisher","first-page":"62","DOI":"10.3389\/fonc.2012.00062","volume":"2","author":"T Vu","year":"2012","unstructured":"Vu, T., & Claret, F. X. (2012). Trastuzumab: Updated mechanisms of action and resistance in breast cancer. Frontiers in Oncology, 2, 62.","journal-title":"Frontiers in Oncology"},{"key":"1021_CR43","doi-asserted-by":"publisher","first-page":"5640","DOI":"10.1182\/blood-2012-01-380121","volume":"119","author":"P Bruhns","year":"2012","unstructured":"Bruhns, P. (2012). Properties of mouse and human IgG receptors and their contribution to disease models. Blood, 119, 5640\u20135649.","journal-title":"Blood"},{"key":"1021_CR44","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1200\/JCO.1997.15.4.1529","volume":"15","author":"MG Steffens","year":"1997","unstructured":"Steffens, M. G., Boerman, O. C., Oosterwijk-Wakka, J. C., Oosterhof, G. O., Witjes, J. A., Koenders, E. B., Oyen, W. J., Buijs, W. C., Debruyne, F. M., Corstens, F. H., & Oosterwijk, E. (1997). Targeting of renal cell carcinoma with iodine-131-labeled chimeric monoclonal antibody G250. Journal of Clinical Oncology, 15, 1529\u20131537.","journal-title":"Journal of Clinical Oncology"},{"key":"1021_CR45","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1053\/gast.2002.37052","volume":"123","author":"MO Gut","year":"2002","unstructured":"Gut, M. O., Parkkila, S., Vernerova, Z., Rohde, E., Zavada, J., Hocker, M., Pastorek, J., Karttunen, T., Gibadulinova, A., Zavadova, Z., Knobeloch, K. P., Wiedenmann, B., Svoboda, J., Horak, I., & Pastorekova, S. (2002). Gastric hyperplasia in mice with targeted disruption of the carbonic anhydrase gene Car9. Gastroenterology, 123, 1889\u20131903.","journal-title":"Gastroenterology"},{"key":"1021_CR46","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1007\/s11248-005-7215-z","volume":"14","author":"M Leppilampi","year":"2005","unstructured":"Leppilampi, M., Karttunen, T. J., Kivela, J., Gut, M. O., Pastorekova, S., Pastorek, J., & Parkkila, S. (2005). Gastric pit cell hyperplasia and glandular atrophy in carbonic anhydrase IX knockout mice: Studies on two strains C57\/BL6 and BALB\/C. Transgenic Research, 14, 655\u2013663.","journal-title":"Transgenic Research"},{"key":"1021_CR47","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.1002\/dvdy.21658","volume":"237","author":"Y Lou","year":"2008","unstructured":"Lou, Y., Preobrazhenska, O., auf dem Keller, U., Sutcliffe, M., Barclay, L., McDonald, P. C., Roskelley, C., Overall, C. M., & Dedhar, S. (2008). Epithelial-mesenchymal transition (EMT) is not sufficient for spontaneous murine breast cancer metastasis. Developmental Dynamics, 237, 2755\u20132768.","journal-title":"Developmental Dynamics"},{"key":"1021_CR48","doi-asserted-by":"publisher","DOI":"10.1002\/0471142735.im2002s39","author":"BA Pulaski","year":"2001","unstructured":"Pulaski, B. A., & Ostrand-Rosenberg, S. (2001). Mouse 4T1 breast tumor model. Current Protocols in Immunology. https:\/\/doi.org\/10.1002\/0471142735.im2002s39","journal-title":"Current Protocols in Immunology"},{"key":"1021_CR49","doi-asserted-by":"publisher","first-page":"1200646","DOI":"10.3389\/fonc.2023.1200646","volume":"13","author":"P Czajka-Francuz","year":"2023","unstructured":"Czajka-Francuz, P., Prendes, M. J., Mankan, A., Quintana, A., Pabla, S., Ramkissoon, S., Jensen, T. J., Peiro, S., Severson, E. A., Achyut, B. R., Vidal, L., Poelman, M., & Saini, K. S. (2023). Mechanisms of immune modulation in the tumor microenvironment and implications for targeted therapy. Frontiers in Oncology, 13, 1200646.","journal-title":"Frontiers in Oncology"},{"key":"1021_CR50","doi-asserted-by":"publisher","first-page":"1153990","DOI":"10.3389\/fimmu.2023.1153990","volume":"14","author":"Y Zheng","year":"2023","unstructured":"Zheng, Y., Li, S., Tang, H., Meng, X., & Zheng, Q. (2023). Molecular mechanisms of immunotherapy resistance in triple-negative breast cancer. Frontiers in Immunology, 14, 1153990.","journal-title":"Frontiers in Immunology"},{"key":"1021_CR51","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1158\/2326-6066.CIR-18-0657","volume":"7","author":"SC Chafe","year":"2019","unstructured":"Chafe, S. C., McDonald, P. C., Saberi, S., Nemirovsky, O., Venkateswaran, G., Burugu, S., Gao, D., Delaidelli, A., Kyle, A. H., Baker, J. H. E., Gillespie, J. A., Bashashati, A., Minchinton, A. I., Zhou, Y., Shah, S. P., & Dedhar, S. (2019). Targeting hypoxia-induced carbonic anhydrase IX enhances immune-checkpoint blockade locally and systemically. Cancer Immunology Research, 7, 1064\u20131078.","journal-title":"Cancer Immunology Research"},{"key":"1021_CR52","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1038\/s41416-020-0756-3","volume":"122","author":"A Giatromanolaki","year":"2020","unstructured":"Giatromanolaki, A., Harris, A. L., Banham, A. H., Contrafouris, C. A., & Koukourakis, M. I. (2020). Carbonic anhydrase 9 (CA9) expression in non-small-cell lung cancer: Correlation with regulatory FOXP3+T-cell tumour stroma infiltration. British Journal of Cancer, 122, 1205\u20131210.","journal-title":"British Journal of Cancer"},{"key":"1021_CR53","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1158\/0008-5472.CAN-14-3000","volume":"75","author":"SC Chafe","year":"2015","unstructured":"Chafe, S. C., Lou, Y., Sceneay, J., Vallejo, M., Hamilton, M. J., McDonald, P. C., Bennewith, K. L., Moller, A., & Dedhar, S. (2015). Carbonic anhydrase IX promotes myeloid-derived suppressor cell mobilization and establishment of a metastatic niche by stimulating G-CSF production. Cancer Research, 75, 996\u20131008.","journal-title":"Cancer Research"}],"container-title":["Molecular Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12033-023-01021-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12033-023-01021-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12033-023-01021-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T10:26:15Z","timestamp":1715336775000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12033-023-01021-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,13]]},"references-count":53,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["1021"],"URL":"https:\/\/doi.org\/10.1007\/s12033-023-01021-5","relation":{},"ISSN":["1073-6085","1559-0305"],"issn-type":[{"value":"1073-6085","type":"print"},{"value":"1559-0305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,13]]},"assertion":[{"value":"12 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}